Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 9/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.35 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.35 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CD40 | P25942 | 1/20 | 0.34 |
| ▸ | CD40LG | P29965 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14388939 | 0.86 | THRB (0.55) | THRBFUT8ENPP2CYP1A2CA2 | |
| SCHEMBL17384028 | 0.85 | SUMO2 (0.46) | THRBFUT8ENPP2CYP1A2PRMT1 | |
| SCHEMBL16624649 | 0.85 | FUT8 (0.52) | THRBFUT8ENPP2CYP1A2CA2 | |
| SCHEMBL13744320 | 0.84 | USP2 (0.37) | THRBFUT8ENPP2CA2CA3 | |
| SCHEMBL18801522 | 0.84 | THRB (0.47) | THRBFUT8ENPP2CYP1A2CA2 | |
| SCHEMBL14983602 | 0.82 | FUT8 (0.48) | THRBFUT8ENPP2CYP1A2CA2 | |
| SCHEMBL14514299 | 0.82 | FUT8 (0.54) | THRBFUT8ENPP2CYP1A2CA2 | |
| SCHEMBL31122162 | 0.82 | THRB (0.75) | THRBENPP2CYP1A2CA2CA3 | |
| SCHEMBL12955080 | 0.82 | THRB (0.75) | THRBENPP2CYP1A2CA2CA3 | |
| SCHEMBL1755507 | 0.82 | THRB (0.75) | THRBENPP2CYP1A2CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090098074-A1 | Keratin-Binding Effector Molecules Containing Reactive Dyes | KRT18, KLK3, KLKB1 | THRB 3581/4885FUT8 2015/4885ENPP2 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.